Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00698165 · ClinicalTrials.gov registry record

Observational Study on Costs and Caregiver Burden in Alzheimer's Disease

A clinical trial of Alzheimers Disease, sponsored by AstraZeneca.

Completed
Registry status
2,400
Enrollment target
20
Study locations

NCT00698165 is a study of Alzheimers Disease that has completed, run by AstraZeneca. The registered enrollment target is 2,400 participants, below the 4,044-participant average among 142 other Alzheimers Disease trials with a reported enrollment target (41% lower). The trial reports 20 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00698165, a study of Alzheimers Disease, has completed, sponsored by AstraZeneca.

COMPLETED
Registry status
2,400 participants
Enrollment target
20
Study locations

Study Summary

Objective of study is to assess the costs of care, objective and subjective caregiver burden and quality of life in relation to disease severity measured by cognitive function, ADL capabilities and presence of behavioral disturbances in Alzheimer's disease

Conditions Studied

Alzheimers Disease

Study Locations (20)

Florida

  • Research Site - Atlantis
  • Research Site - Fort Myers
  • Research Site - Miami
  • Research Site - Port Charlotte
  • Research Site - Tampa
  • Research Site - Titusville
  • Research Site - Venice

Georgia

  • Research Site - Canton
  • Research Site - Columbus
  • Research Site - Decatur
  • Research Site - Dunwoody
  • Research Site - Snellville

California

  • Research Site - Brentwood
  • Research Site - Fresno
  • Research Site - La Habra
  • Research Site - Long Beach

Alabama

  • Research Site - Northport

Arizona

  • Research Site - Phoenix

Colorado

  • Research Site - Denver

Connecticut

  • Research Site - Wetherfield

Trial Details

FieldValue
Enrollment Target 2,400 participants
Start Date 2007-06
Est. Completion 2009-01

Sponsor

AstraZeneca

1,285 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00698165

The ClinicalTrials.gov registry entry for NCT00698165 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,044-participant average among 142 other Alzheimers Disease trials with a reported enrollment target (41% lower). The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alzheimers Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00698165 reports 20 study locations spanning 7 distinct geographic areas - top geographies include Florida, Georgia, California.

Frequently Asked Questions

What is clinical trial NCT00698165 about?

NCT00698165 is a clinical study titled "Observational Study on Costs and Caregiver Burden in Alzheimer's Disease". Objective of study is to assess the costs of care, objective and subjective caregiver burden and quality of life in relation to disease severity measured by cognitive function, ADL capabilities and presence of behavioral disturbances in Alzheimer's disease

What is the current status of trial NCT00698165?

This trial is currently completed. The enrollment target is 2,400 participants. The study started on 2007-06. Estimated completion is 2009-01.

What conditions does trial NCT00698165 study?

This clinical trial studies the following conditions: Alzheimers Disease.

Who is sponsoring clinical trial NCT00698165?

This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00698165 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimers Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimers Disease

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.